Submission Details
| 510(k) Number | K202868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 28, 2020 |
| Decision Date | July 21, 2021 |
| Days to Decision | 296 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K202868 is an FDA 510(k) clearance for the LifeSignals Multi-Parameter Remote Monitoring Platform, a Transmitters And Receivers, Physiological Signal, Radiofrequency (Class II — Special Controls, product code DRG), submitted by Lifesignals, Inc. (Fremont, US). The FDA issued a Cleared decision on July 21, 2021, 296 days after receiving the submission on September 28, 2020. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.2910.
| 510(k) Number | K202868 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 28, 2020 |
| Decision Date | July 21, 2021 |
| Days to Decision | 296 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DRG — Transmitters And Receivers, Physiological Signal, Radiofrequency |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.2910 |